Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIA.
about
Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewSorafenib in breast cancer treatment: A systematic review and overview of clinical trialsA randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO).Sorafenib for the treatment of breast cancer.
P2860
Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIA.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Sorafenib in the Treatment of ...... juvant Phase II Study - SOFIA.
@ast
Sorafenib in the Treatment of ...... juvant Phase II Study - SOFIA.
@en
Sorafenib in the Treatment of ...... juvant Phase II Study - SOFIA.
@nl
type
label
Sorafenib in the Treatment of ...... juvant Phase II Study - SOFIA.
@ast
Sorafenib in the Treatment of ...... juvant Phase II Study - SOFIA.
@en
Sorafenib in the Treatment of ...... juvant Phase II Study - SOFIA.
@nl
prefLabel
Sorafenib in the Treatment of ...... juvant Phase II Study - SOFIA.
@ast
Sorafenib in the Treatment of ...... juvant Phase II Study - SOFIA.
@en
Sorafenib in the Treatment of ...... juvant Phase II Study - SOFIA.
@nl
P2093
P2860
P50
P356
P1433
P1476
Sorafenib in the Treatment of ...... juvant Phase II Study - SOFIA.
@en
P2093
Bernd Gerber
Bettina Conrad
Dennis Rokitta
Iris Schrader
Kathrin Schwedler
Keyur Mehta
Mathias Warm
Michaela Wüllner
P2860
P304
P356
10.1159/000363430
P577
2014-07-01T00:00:00Z